Abstracts

324 – Novel Strategy to Inhibit HIV by Targeting Integrase/INI1 Interaction Based on the TAR RNA Mimicry

Background Targeting host-virus interactions is an attractive strategy to overcome the problem of HIV-1 drug resistance. INI1/SMARCB1 is an HIV-1 integrase (IN)-interacting host factor required for assembly and particle production. Studies from our laboratory has indicated that IN binding Rpt1 domain of INI1 (INI1-Rpt1) and viral TAR RNA structurally mimic each other and bind to…

330 – A Virus-Packageable CRISPR Screen to Uncover Genes Underlying SIVcpz Replication in Human Cells

Background Human immunodeficiency virus (HIV) is the result of the cross-species transmission of simian immunodeficiency viruses (SIVs) that endemically infect non-human primates. While pandemic HIV-1 M is the result of a chimpanzee lentivirus (SIVcpz) cross-species transmission to humans, lentiviruses from other non-human primates have also spilled over into humans. Since the emergence of HIV, the…

348 – Species-Specific Splicing of DNA Editing Enzymes: Implications in HIV and SIV Mutagenesis

Background Humans and nonhuman primates (NHPs) possess seven APOBEC3 (A3) enzymes, which restrict various viruses, notably HIV in humans and SIV in NHPs. These antiviral proteins inhibit viral infection by inducing G>A mutations in viral genomes and/or through mutation-independent mechanisms. HIV and SIV counteract A3 enzymes via their virion infectivity factor (Vif), which promotes A3…

377 – Acute HIV-1 Infection Triggers Myelopoiesis Suppression and Pancytopenia Through IFN-γ Signaling

Background HIV-1 infection commonly causes multiple hematopoietic abnormalities, known as pancytopenia, including lymphopenia, anemia, granulocytopenia, and thrombocytopenia, suggesting a central deficiency in bone marrow hematopoiesis. However, the mechanism by which HIV-1 infection leads to bone marrow hematopoietic defects remains unknown due to the lack of appropriate in vivo models. In this study, we established a…

323 – Host Gene SLC35A2 Restricts CXCR4-Tropic HIV-1 Replication at the Stage of Viral Fusion

Background Despite the diversity of HIV-1 variants in a chronically infected individual, during transmission, only a few variants seed new infections. These founder viruses predominantly utilize the CCR5 co-receptor to facilitate viral entry into CD4 T cells over the CXCR4 co-receptor. The host factors that contribute to this transmission bottleneck are not well understood. We have…

311 – Evolving of Immune Evasion During a SARS-CoV-2 Chronic Infection: A Pathway to Variants of Concern

Background Acute SARS-CoV-2 infections are mostly cleared within a few days but can become chronic in immunocompromised individuals. Impaired immune clearance is also thought to be a major factor in the evolution of new SARS-CoV-2 variants of concern(VOC). However, it is unclear how intra-host variation accumulates over the course of very long-term chronic SARS-CoV-2 infection,…

326 – The Effects of Accessory Genes on T/F HIV Infection of Primary CD4+ T Cells From Tissues

Background HIV transmission typically results from infection by a single a transmitted/founder (T/F) virus. Accessory genes of T/F HIV often exhibit functions lost in cell culture-adapted HIV strains. Understanding the effects of accessory proteins from T/F HIV on infected cells is important for understanding HIV pathogenesis. Previous work has established that accessory proteins Nef, Vpu,…

353 – Genetic Associations With CD4 Recovery in People With HIV After Initiation of Antiretroviral Therapy

Background CD4+ T-cell recovery varies among people with HIV (PWH) who are virologically suppressed on antiretroviral therapy (ART). Our objective was to identify the genetic predictors of CD4 recovery measured by the slope of longitudinal CD4+ T-cell counts within two years after ART initiation in PWH virologically suppressed on ART. We hypothesized that select single…